Journal
EXPERT REVIEW OF NEUROTHERAPEUTICS
Volume 20, Issue 2, Pages 167-173Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14737175.2020.1707668
Keywords
Antiepileptic polytherapy; drug-resistant epilepsy; antiepileptic drugs combinations; synergism; pharmacokinetics; tolerability
Categories
Ask authors/readers for more resources
Introduction: Antiepileptic polytherapy may be indicated in patients experiencing drug-resistant epilepsy. To date, there are no evidence-based criteria on how to combine different antiepileptic drugs (AEDs) together, in order to obtain the best therapeutic response. Areas covered: This paper reviews the available data about the various associations of AEDs in patients undergoing polytherapy, focusing on the most effective and well-tolerated polytherapies. Moreover, some controversial aspects of this topic are addressed. Expert opinion: Nowadays, there are no guidelines on polytherapy in patients with epilepsy; thus, the management of pharmacoresistant epilepsy is still uncertain, except for valproate/lamotrigine combination, which seems to be the only one recommended. Data regarding mechanism of action, pharmacokinetics, tolerability, and, more importantly, the analysis of the valuable clinical studies of drug combinations can help physicians to choose the best and most effective AED association for each patient.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available